Cancer Gateway

Welcome to BioMed Central's Cancer Gateway, highlighting the latest articles we have published in this field. Content is continually updated, so please bookmark this page and ensure you check it regularly.

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: istock

    Blood group and mortality risk

    Recent findings suggest nearly 6% of total deaths and 9% of cardiovascular deaths could be due to having non-O blood groups; Massimo Franchini and Giuseppe Lippi discuss possible mechanisms of these associations and the clinical implications.

    BMC Medicine 2015, 13:7
  • Image attributed to: Wikipedia: U.S. Navy

    Higher mortality rate for non-O blood groups 

    Individuals with non-O blood groups have an increased rate of all-cause mortality and incident gastric cancer, possibly through the effects on blood biochemistry, supporting the clinical importance of blood group determination in assessing health risks.

    BMC Medicine 2015, 13:8
  • ADAR2 in glioblastoma

    ADAR2 modulates miRNA expression and editing in glioblastoma

    Genome Biology 2015, 16:5
  • Image attributed to: Flickr (CC, Jaso)

    Diet and prostate cancer

    Pao-Hwa Lin and colleagues review recent evidence for the effect of diet on prostate cancer incidence and progression, concluding that while some findings are inconsistent, consuming a healthy diet is a promising approach for prostate cancer prevention.

    BMC Medicine 2015, 13:3
  • Fusion gene detection

    TRUP is a method for detecting fusion genes in RNA-seq data from tumor specimens

    Genome Biology 2015, 16:7

AuthorMapper

Authors of BioMed Central cancer-related articles, by location

Powered by AuthorMapper.com

News and events

Biomarker Research, a new journal encompassing all aspects biomarker investigation, has now launched. Visit the journal website to read the first articles, including a review by co-Editor-in-Chief Delong Liu on the clinical applications of JAK inhibitors, and sign up for article alerts.

ez-reprint

Author profile

Wei Zhang

Director, Cancer Genomics Core Lab, University of Texas